融合基因
核型
免疫分型
髓系白血病
荧光原位杂交
生物
白血病
癌症研究
基因重排
融合转录本
遗传学
基因
染色体
流式细胞术
出处
期刊:Clinical Laboratory
[Clinical Laboratory Publications]
日期:2022-01-01
卷期号:68 (12/2022)
标识
DOI:10.7754/clin.lab.2022.220313
摘要
The SET-NUP214 fusion formed by cryptic t(9;9)(q34;q34) or del(9)(q34.11q34.13) is a rare gene rearrangement. This rearrangement has been reported mostly in T-cell acute lymphoblastic leukemia, but only rarely in acute myeloid leukemia (AML). The acute leukemia cases with the SET-NUP214 fusion gene show typical immunophenotype, karyotype, and poor treatment response. However, the cytogenetic or genetic changes in AML with SET-NUP214 fusion are not well understood.The diagnosis was made based on a combination of the morphology, immunophenotyping, multiplex reverse transcriptase-polymerase chain reaction, FISH, karyotype, Sanger sequencing, next-generation sequencing, and microarray analysis.The author reports a rare case of AML with myelodysplasia-related changes, SET-NUP214 fusion gene, and complex karyotype that was resistant to induction chemotherapy, making diagnosis and treatment difficult.Further studies, including cytogenetic and molecular analyses, are needed to determine the pathophysiology and clinical significance for this rare gene rearrangement.
科研通智能强力驱动
Strongly Powered by AbleSci AI